ANTISENSE PHARMA GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
2404 MATERIALS FOR DRESSING WOUNDS, NURSING AND MEDICAL CARE125
 
 
 
2402 MEDICAL INSTRUMENTS, INSTRUMENTS AND TOOLS FOR LABORATORY USE142

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8936910 Method for selective oligonucleotide modificationJun 10, 11Jan 20, 15[C07H, C12Q, C12N]
8822425 Dosage of oligonucleotides suitable for the treatment of tumorsMay 12, 09Sep 02, 14[C07H, C12N]
D709183 Pump for pharmaceutical and cosmetic productsSep 28, 12Jul 15, 14[2404]
D697204 Pump for pharmaceutical and cosmetics productsSep 27, 12Jan 07, 14[2402]
8476246 Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta systemJul 30, 10Jul 02, 13[C07H, A01N, C12Q, C12N]
8177775 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery techniqueFeb 14, 11May 15, 12[A61K, A61M]
8097597 Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumorsMay 04, 06Jan 17, 12[A61K, C07H]
7963956 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery techniqueApr 22, 03Jun 21, 11[A61K, A61M]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2012/0208,774 METHOD FOR INHIBITING "MELANOMA INHIBITORY ACTIVITY" MIAAbandonedFeb 27, 12Aug 16, 12[A61K, C07K]
2011/0136,893 OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATESAbandonedDec 21, 07Jun 09, 11[A61K, C07H, A61P]
7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIAExpiredAug 11, 04Mar 22, 11[C07H, A61K, C12N]
2010/0160,208 Pharmaceutical compositionAbandonedSep 02, 09Jun 24, 10[A61K]
2007/0196,269 Pharmaceutical compositionAbandonedDec 20, 04Aug 23, 07[A61K]
2007/0155,685 Pharmaceutical compositionAbandonedFeb 28, 05Jul 05, 07[A61K, C07H]
2006/0128,607 Method for inhibiting "melanoma inhibitory activity" miaAbandonedJan 29, 02Jun 15, 06[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.